Valion Bio regains Nasdaq compliance with $1 minimum bid price rule

• Valion Bio regained compliance with Nasdaq’s $1 minimum bid price rule under Listing Rule 5550(a)(2).
• Nasdaq notified the company that it met the requirement by holding a closing bid of at least $1 for the required period.
• Nasdaq’s listing staff closed the compliance matter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.